Mark Yen

1.1k citations
17 papers · 852 · 1 hit paper · h-index 10

Impact in

  • Physiology top 5%
    • Alzheimer's disease research and treatments
  • Urology top 5%
    • Urinary Bladder and Prostate Research

Papers in

    • Alzheimer's disease research and treatments 5
    • Antibiotics Pharmacokinetics and Efficacy 2

Mark Yen

15 papers receiving 817 citations

Mark Yen's Hit Papers

Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis 2024 · 53 citations
530+1Years since publication1020304050

Peers

Mark Yen
Comparison fields: 5 of 69
  • Physiology 343
  • Urology 50
  • Neurology 64
  • Infectious Diseases 70
  • Neurology 29
Replace David E. Reed with:
David E. Reed Canada
Reiko Ichikawa Japan
Mykhaylo V Artamonov United States
Laszlo Karai United States
Barbara Gisevius Germany
Ji‐Hye Hwang South Korea
Masayori Kagoura Japan
Tapio Nevalainen Finland
Joonho Park South Korea
Quanlong Jiang China
Mark Yen relative to David E. Reed Canada David E. Reed's profile →
Citations per field
00.5×2×4×6×8×9.1×
David E. Reed · 1×
Citations per year

Countries citing papers authored by Mark Yen

Since Specialization
Citations

This map shows the geographic impact of Mark Yen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Yen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Yen more than expected).

Fields of papers citing papers by Mark Yen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Yen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Yen. The network helps show where Mark Yen may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Yen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Yen Line = papers co-authored together Mark Yen links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 2011330
2 2012130
3 201779
4 201766
5
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis
Hit paper breakdown →
202453
6 200850
7 201250
8 201429
9 202520
10 201515
11 20159
12 20098
13 20097
14 20105
15 20111
16 20120
17 20250

About Mark Yen

Mark Yen is a scholar working on Physiology, Pharmacology, Genetics, Immunology and Cardiology and Cardiovascular Medicine, having authored 17 papers that have together received 852 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Inflammatory Bowel Disease (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Cardiac electrophysiology and arrhythmias (2 papers), Pharmaceutical studies and practices (1 paper), Parkinson's Disease Mechanisms and Treatments (1 paper), Bacterial Infections and Vaccines (1 paper) and Schizophrenia research and treatment (1 paper). The work is most often cited by research in Physiology (343 citations), Urology (50 citations), Neurology (64 citations), Infectious Diseases (70 citations) and Neurology (29 citations). Mark Yen has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include James J. Keirns, Donna L. Kowalski, SALIM K. MUJAIS, Larry Ereshefsky, Selina Moy, Marek Malík, Marloes P. Schaddelee, Paul De Koning, E. Marcel van Gelderen and Ronald Goldwater. Their work appears in journals such as Alzheimer s & Dementia, Clinical Pharmacology & Therapeutics, Gastroenterology, Biomarkers in Medicine and International Clinical Psychopharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact